What Is the Best Choice for Combination Therapy in the Management of Dyslipidemia of Metabolic Syndrome?

Publisher： Karger

E-ISSN： 1421-9751|105|3|139-140

ISSN： 0008-6312

Source： Cardiology, Vol.105, Iss.3, 2006-04, pp. : 139-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

How to best define the metabolic syndrome

By Magliano Dianna   Shaw Jonathan   Zimmet Paul  

Annals of Medicine, Vol. 38, Iss. 1, 2006-03 ,pp. : 34-41

Informa Healthcare

Access to resources Recommend Favorite

Low testosterone and the metabolic syndrome: a high‐risk combination

By  

TRENDS IN UROLOGY AND MEN'S HEALTH, Vol. 2044-3730, Iss. 5, 2015-09 ,pp. : 26-30

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low testosterone and the metabolic syndrome: a high‐risk combination

By  

TRENDS IN UROLOGY AND MEN'S HEALTH, Vol. 6, Iss. 5, 2015-09 ,pp. : 26-30

John Wiley & Sons Inc

Access to resources Recommend Favorite

Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome

By                          

International Journal of Molecular Medicine, Vol. 30, Iss. 1, 2012-01 ,pp. : 185-192

Spandidos Publications

Access to resources Recommend Favorite

Combination Therapy for Pulmonary Artery Hypertension: What Is the Evidence?

By  

Cardiology, Vol. 120, Iss. 3, 2012-01 ,pp. : 172-173

Karger

Access to resources Recommend Favorite